UPDATE ON AVAILABILITY OF COVID-19 VACCINES

The Sinovac-CoronaVac COVID-19 vaccine will cease to be offered under the National Vaccination Programme (NVP) after 30 September 2024. As we have transited to manage COVID-19 as an endemic disease, the Health Sciences Authority (HSA) requires all COVID-19 vaccines to be fully registered, as opposed to being used under emergency authorisation during the pandemic. As there has been no application to HSA for the Sinovac-CoronaVac COVID-19 vaccine to be fully registered, the vaccine will cease to be offered under the NVP. Eligible individuals who wish to receive the Sinovac-CoronaVac COVID-19 vaccine are advised to do so by 30 September 2024.

2. The Ministry of Health (MOH) had, on 28 October 2023, announced that the Sinovac-CoronaVac COVID-19 vaccine would no longer be available under the NVP should there be no application for it to be fully registered. As production has stopped, the supply of the Sinovac-CoronaVac COVID-19 vaccine is currently not commercially available in Singapore, and private clinics are also unable to provide it under the Special Access Route. 

3. The COVID-19 vaccines of Pfizer-BioNTech/Comirnaty, Moderna/Spikevax and Novavax/Nuvaxovid have been fully registered with HSA and will continue to be provided under the NVP. 

4. Individuals may book an appointment at a participating General Practitioner (GP) clinic through https://book.health.gov.sg/covid, or at a polyclinic through the HealthHub booking system. Alternatively, they can walk into any of the five Joint Testing and Vaccination Centres. Please refer to https://gowhere.gov.sg/vaccine to locate the nearest vaccination sites and the COVID-19 vaccines offered. 

5. COVID-19 waves will continue to occur from time to time and can cause severe disease among those who are older or medically vulnerable. MOH advises the public to keep up to date with their COVID-19 vaccination, as it can prevent severe COVID-19 illness. All persons aged 60 years and above, medically vulnerable individuals and residents of aged care facilities are recommended to receive an additional dose of vaccine around one year after the last dose, but no earlier than five months.